• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹部肥胖与腹内压:性腺功能减退-肥胖-良性前列腺增生-下尿路症状关联发病机制的新范式

Abdominal obesity and intra-abdominal pressure: a new paradigm for the pathogenesis of the hypogonadal-obesity-BPH-LUTS connection.

作者信息

Cohen Paul G

出版信息

Horm Mol Biol Clin Investig. 2012 Oct;11(1):317-20. doi: 10.1515/hmbci-2012-0030.

DOI:10.1515/hmbci-2012-0030
PMID:25436690
Abstract

Abstract The pathogenesis of benign prostatic hyperplasia-lower urinary tract symptoms (BPH-LUTS) is complicated, multifactorial, and incompletely understood. A number of recent observations have provided for new insights and offer a better appreciation for, and the understanding of, the pathophysiological and hormonal contributions for the development and progression of prostatic enlargement. A major paradox has been the progressive increase in the prostate size at a time when the peripheral blood testosterone levels are decreasing as men age. This has been associated with the findings of increasing obesity-related states and the manifestation of BPH-LUTS. Several converging and new findings combine the mechanisms that result in an integration of the hypogonadal-obesity-increased intra-abdominal pressure (IAP)-BPH-LUTS connection. The net positive caloric balance results increased the IAP and damaged the one-way valves of the internal spermatic veins. This results in an increased venous back pressure that leads to the reflux of the high testicular testosterone concentrations and venous pressures that are transmitted to the communicating prostatic venous system. Simultaneously, increasing obesity results in an increased aromatase activity, which leads to a reduction of the testosterone levels. Consequently, there is also an increased estradiol production, which inhibits gonadotropin secretion and the production of testosterone. This hypogonadal obesity cycle eventually results in a progressive hypogonadal state, while the prostate continues to enlarge and produce increasing LUTS.

摘要

摘要 良性前列腺增生伴下尿路症状(BPH-LUTS)的发病机制复杂、多因素且尚未完全明确。近期的一些观察结果提供了新的见解,有助于更好地理解前列腺增生发展和进展的病理生理及激素方面的影响。一个主要的矛盾是,随着男性年龄增长,外周血睾酮水平下降时前列腺体积却在逐渐增大。这与肥胖相关状态增加及BPH-LUTS的表现有关。一些相互关联的新发现结合了导致性腺功能减退-肥胖-腹内压升高(IAP)-BPH-LUTS联系整合的机制。热量摄入净正平衡导致IAP升高,并损害精索内静脉的单向瓣膜。这导致静脉回压增加,进而导致高浓度睾丸睾酮和静脉压力反流至与之相通的前列腺静脉系统。同时,肥胖加剧导致芳香化酶活性增加,从而使睾酮水平降低。因此,雌二醇生成也增加,抑制促性腺激素分泌和睾酮生成。这种性腺功能减退-肥胖循环最终导致性腺功能逐渐减退,而前列腺持续增大并产生越来越多的下尿路症状。

相似文献

1
Abdominal obesity and intra-abdominal pressure: a new paradigm for the pathogenesis of the hypogonadal-obesity-BPH-LUTS connection.腹部肥胖与腹内压:性腺功能减退-肥胖-良性前列腺增生-下尿路症状关联发病机制的新范式
Horm Mol Biol Clin Investig. 2012 Oct;11(1):317-20. doi: 10.1515/hmbci-2012-0030.
2
Benign prostatic hyperplasia: the hypogonadal-obesity-prostate connection.良性前列腺增生:性腺功能减退-肥胖-前列腺之间的联系。
Med Hypotheses. 2009 Aug;73(2):142-3. doi: 10.1016/j.mehy.2009.03.013. Epub 2009 Apr 24.
3
A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.一种新型与良性前列腺增生相关的勃起功能障碍和下尿路症状的实验性大鼠模型:补充睾酮的自发性高血压大鼠。
BJU Int. 2012 Nov;110(9):1352-8. doi: 10.1111/j.1464-410X.2012.11085.x. Epub 2012 Mar 27.
4
Reversal of benign prostate hyperplasia by selective occlusion of impaired venous drainage in the male reproductive system: novel mechanism, new treatment.通过选择性阻塞男性生殖系统中受损的静脉引流来逆转良性前列腺增生:新机制,新疗法。
Andrologia. 2008 Oct;40(5):273-81. doi: 10.1111/j.1439-0272.2008.00883.x.
5
The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt--a major factor in the genesis of morbid obesity.性腺功能减退-肥胖循环:芳香化酶在调节睾酮-雌二醇分流中的作用——病态肥胖发生的一个主要因素。
Med Hypotheses. 1999 Jan;52(1):49-51. doi: 10.1054/mehy.1997.0624.
6
Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.疑似良性前列腺增生的下尿路症状的治疗:性功能
BJU Int. 2005 Jun;95 Suppl 4:12-8. doi: 10.1111/j.1464-410X.2005.05486.x.
7
BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.良性前列腺增生进展:来自MTOPS、ALTESS、COMBAT和ALF-ONE的概念及关键认识。
BJU Int. 2008 Mar;101 Suppl 3:17-21. doi: 10.1111/j.1464-410X.2008.07497.x.
8
Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.韩国中年警察的下尿路症状/良性前列腺增生措施与国际勃起功能指数 5 的关系,以及代谢综合征和睾酮在其中的作用。
Urology. 2013 Nov;82(5):1008-12. doi: 10.1016/j.urology.2013.07.003. Epub 2013 Sep 13.
9
Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.性功能障碍与下尿路症状/良性前列腺增生之间关系的最新进展。
Curr Opin Urol. 2006 Jan;16(1):11-9.
10
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?当前下尿路症状/BPH 的医学治疗:我们有标准吗?
Curr Opin Urol. 2014 Jan;24(1):21-8. doi: 10.1097/MOU.0000000000000007.

引用本文的文献

1
Low lean mass is associated with lower urinary tract symptoms in US men from the 2005-2006 national health and nutrition examination survey dataset.在美国 2005-2006 年全国健康和营养调查数据集的男性中,低肌肉质量与下尿路症状有关。
Aging (Albany NY). 2021 Sep 2;13(17):21421-21434. doi: 10.18632/aging.203480.
2
Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia.一生中的身体大小与良性前列腺增生相关结局和夜间多尿的发生。
BMC Urol. 2021 Mar 27;21(1):47. doi: 10.1186/s12894-021-00816-5.
3
Factors Associated with Bothersome Lower Urinary Tract Symptoms in Middle-Aged Men Receiving Health Checkup.
与接受健康检查的中年男性烦人的下尿路症状相关的因素。
Sci Rep. 2019 Jan 29;9(1):901. doi: 10.1038/s41598-018-37605-4.
4
Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms.患有中重度下尿路症状的性腺功能减退男性比仅有轻度下尿路症状的男性具有更严重的代谢综合征心血管风险特征,并且从睾酮治疗中获益更多。
Investig Clin Urol. 2018 Nov;59(6):399-409. doi: 10.4111/icu.2018.59.6.399. Epub 2018 Nov 2.
5
Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome.睾酮缺乏及睾酮治疗对代谢综合征男性下尿路症状的影响
World J Mens Health. 2018 Sep;36(3):199-222. doi: 10.5534/wjmh.180032. Epub 2018 Jul 3.
6
Metabolic syndrome and benign prostatic hyperplasia: An update.代谢综合征与良性前列腺增生:最新进展
Asian J Urol. 2017 Jul;4(3):164-173. doi: 10.1016/j.ajur.2017.05.001. Epub 2017 May 25.
7
Positive Response to Thermobalancing Therapy Enabled by Therapeutic Device in Men with Non-Malignant Prostate Diseases: BPH and Chronic Prostatitis.治疗设备实现的热平衡疗法对患有非恶性前列腺疾病(良性前列腺增生和慢性前列腺炎)的男性产生积极反应。
Diseases. 2016 Apr 18;4(2):18. doi: 10.3390/diseases4020018.